Thermo Fisher Scientific Inc (TMO)

Director CASPER MARC N 🟡 adjusted position in 10.0K shares (1 derivative) of THERMO FISHER SCIENTIFIC INC. (TMO) at $502.26 ($10.1M) Transaction Date: Aug 22, 2025 | Filing ID: 000108

Register to leave comments

  • News bot Aug. 26, 2025, 8:33 p.m.

    🔍 CASPER MARC N (Director)

    Company: THERMO FISHER SCIENTIFIC INC. (TMO)

    Report Date: 2025-08-22

    Transaction Summary:

    • Total transactions: 8
    • Derivative instruments: 1
    • Holdings reported: 3
    • Total shares acquired: 10,000
    • Total shares sold: 20,000
    • Total shares held: 30,908

    Detailed Transactions and Holdings:

    • Acquired 10,000 shares of Common Stock at $253.99 per share (Direct)
      Date: 2025-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 125,173.62 | transaction_form_type: 4
    • Sold 5,823 shares of Common Stock at $500.4 per share (Direct)
      Date: 2025-08-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 119,350.62 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 3,579 shares of Common Stock at $501.65 per share (Direct)
      Date: 2025-08-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 115,771.62 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 598 shares of Common Stock at $502.26 per share (Direct)
      Date: 2025-08-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 115,173.62 | transaction_form_type: 4 | Footnotes: F1, F4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-08-22 | Code: H | nature_of_ownership: By Alison Casper 2020 Irrevocable Trust | shares_owned_after: 11,300.00 | Footnotes: F5
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-08-22 | Code: H | nature_of_ownership: By Floral Park Associates, Inc. | shares_owned_after: 14,608.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-08-22 | Code: H | nature_of_ownership: By MNC 2020 Irrevocable Trust | shares_owned_after: 5,000.00 | Footnotes: F6
    • Sold 10,000 shares of Stock Option (Right to Buy) at $253.99 per share (Derivative)
      Date: 2025-08-22 | Code: M | Expires: 2026-02-26 | equity_swap_involved: 0 | shares_owned_after: 24,754.00 | transaction_form_type: 4 | Footnotes: F7

    Footnotes:

    • F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 28, 2025.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $500.001 to $500.98, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.05 to $501.99, inclusive.
    • F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $502.02 to $502.37, inclusive.
    • F5: The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
    • F6: The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
    • F7: The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023.